尊龙凯时·「中国区」官方网站

About
us
Learn more
Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Limited
International pharmaceutical enterprises of scientific and technological innovation
Grand Pharmaceutical Group Co., Ltd. (stock code: 00512. HK) is a research-based international pharmaceutical enterprise that specialises in pharmaceutical technology, nuclear medicine anti-tumor diagnosis and treatment and cerebro-cardiovascular precision interventional diagnosis and treatment technology and biotechnology.
8 +

R&D Centers

700 +

R&D People

141 +

Projects in Progress

Global R&D Map
Internationalization
Learn more
Dare to be the first and share the success
Dare to be the first and share the success
In recent years, Grand Pharma has deployed a series of innovative pharmaceutical products with broad market in the United States, Australia, Germany and other countries. Our Group has established strong partnerships with the world's leading pharmaceutical companies, universities and research institutes, and achieved a rich and diversified product pipeline in a range of medical therapeutic areas. Grand Pharma has already invested and operated 5 R&D technology platforms and 8 R&D centres worldwide.
Core Business Areas

ENT Segment

Respiratory and Critical and Severe Disease Segment

Cerebro-cardiovascular Segment

Pharmaceutical Raw Materials Segment

mRNA platform

Nuclear Medicine Anti-tumor Diagnosis and Treatment Segment

Cerebro-cardiovascular Precision Interventional Diagnosis and Treatment Segment

Amino Acids Segment

PHARMACEUTICAL TECHNOLOGY

NUCLEAR MEDICINE ANTI-TUMOR DIAGNOSIS AND TREATMENT AS WELL AS CEREBRO- CARDIOVASCULAR PRECISION INTERVENTIONAL DIAGNOSIS AND TREATMENT TECHNOLOGY

BIOTECHNOLOGY

友情链接: